SH3PXD2A


Summary:

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
SH3 and PX domains 2AEnsembl:ENSG00000107957HGNC:HGNC:23664PA13495681610q24.33

GO terms in SH3PXD2A


Term TypeEvidence TypeGO Term IDGO Des.
CCIDAGO:0002102podosome
CCTASGO:0005829cytosol
CCIEAGO:0030054cell junction
CCIEAGO:0042995cell projection
BPIBAGO:0006801superoxide metabolic process
BPIDAGO:0006801superoxide metabolic process
BPIMPGO:0006801superoxide metabolic process
BPTASGO:0030198extracellular matrix organization
BPIEAGO:0043085positive regulation of catalytic activity
BPIMPGO:0072675osteoclast fusion
MFIEAGO:0002020protease binding
MFIPIGO:0005515protein binding
MFIEAGO:0005546phosphatidylinositol-4,5-bisphosphate binding
MFIEAGO:0010314phosphatidylinositol-5-phosphate binding
MFIBAGO:0016176superoxide-generating NADPH oxidase activator activity
MFIEAGO:0032266phosphatidylinositol-3-phosphate binding
MFIBAGO:0035091phosphatidylinositol binding
MFIEAGO:0043325phosphatidylinositol-3,4-bisphosphate binding
MFIEAGO:0070273phosphatidylinositol-4-phosphate binding

Gene expression in normal tissue: SH3PXD2A

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in SH3PXD2A


DatabasePathway IDPathway Des.
reactomeR-HSA-1474244Extracellular matrix organization
reactomeR-HSA-8941237Invadopodia formation

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD284Palbociclib1
iGMDRD536PLX-47201

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in SH3PXD2A

​​​​